0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Viral Molecular Diagnostics Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-7B1914
Home | Market Reports | Science
Global Viral Molecular Diagnostics Market Insights and Forecast to 2028
BUY CHAPTERS

Global Viral Molecular Diagnostics Market Research Report 2025

Code: QYRE-Auto-7B1914
Report
August 2025
Pages:77
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Viral Molecular Diagnostics Market Size

The global market for Viral Molecular Diagnostics was valued at US$ 9181 million in the year 2024 and is projected to reach a revised size of US$ 14840 million by 2031, growing at a CAGR of 7.2% during the forecast period.

Viral Molecular Diagnostics Market

Viral Molecular Diagnostics Market

Molecular diagnostics refers to a technique used to detect and identify the presence of genetic material or proteins associated with a specific health condition or disease.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Viral Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Molecular Diagnostics.
The Viral Molecular Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Viral Molecular Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Viral Molecular Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Viral Molecular Diagnostics Market Report

Report Metric Details
Report Name Viral Molecular Diagnostics Market
Accounted market size in year US$ 9181 million
Forecasted market size in 2031 US$ 14840 million
CAGR 7.2%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Hepatitis B Virus (HBV)
  • Hepatitis C Virus (HCV)
  • Human Immunodeficiency Virus (HIV)
  • Human Papillomavirus (HPV)
Segment by Application
  • Hospitals
  • Academics Institutions
  • Laboratories
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott Laboraories, Bio-Rad Laboratories, Becton, Dickinson, Roche, Gen-Probe, Qiagen, Olympus, Thermo Fisher Scientific
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Viral Molecular Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Viral Molecular Diagnostics Market growing?

Ans: The Viral Molecular Diagnostics Market witnessing a CAGR of 7.2% during the forecast period 2025-2031.

What is the Viral Molecular Diagnostics Market size in 2031?

Ans: The Viral Molecular Diagnostics Market size in 2031 will be US$ 14840 million.

Who are the main players in the Viral Molecular Diagnostics Market report?

Ans: The main players in the Viral Molecular Diagnostics Market are Abbott Laboraories, Bio-Rad Laboratories, Becton, Dickinson, Roche, Gen-Probe, Qiagen, Olympus, Thermo Fisher Scientific

What are the Application segmentation covered in the Viral Molecular Diagnostics Market report?

Ans: The Applications covered in the Viral Molecular Diagnostics Market report are Hospitals, Academics Institutions, Laboratories, Others

What are the Type segmentation covered in the Viral Molecular Diagnostics Market report?

Ans: The Types covered in the Viral Molecular Diagnostics Market report are Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV), Human Papillomavirus (HPV)

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Molecular Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Hepatitis B Virus (HBV)
1.2.3 Hepatitis C Virus (HCV)
1.2.4 Human Immunodeficiency Virus (HIV)
1.2.5 Human Papillomavirus (HPV)
1.3 Market by Application
1.3.1 Global Viral Molecular Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Academics Institutions
1.3.4 Laboratories
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Viral Molecular Diagnostics Market Perspective (2020-2031)
2.2 Global Viral Molecular Diagnostics Growth Trends by Region
2.2.1 Global Viral Molecular Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Viral Molecular Diagnostics Historic Market Size by Region (2020-2025)
2.2.3 Viral Molecular Diagnostics Forecasted Market Size by Region (2026-2031)
2.3 Viral Molecular Diagnostics Market Dynamics
2.3.1 Viral Molecular Diagnostics Industry Trends
2.3.2 Viral Molecular Diagnostics Market Drivers
2.3.3 Viral Molecular Diagnostics Market Challenges
2.3.4 Viral Molecular Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Viral Molecular Diagnostics Players by Revenue
3.1.1 Global Top Viral Molecular Diagnostics Players by Revenue (2020-2025)
3.1.2 Global Viral Molecular Diagnostics Revenue Market Share by Players (2020-2025)
3.2 Global Viral Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Viral Molecular Diagnostics Revenue
3.4 Global Viral Molecular Diagnostics Market Concentration Ratio
3.4.1 Global Viral Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Molecular Diagnostics Revenue in 2024
3.5 Global Key Players of Viral Molecular Diagnostics Head office and Area Served
3.6 Global Key Players of Viral Molecular Diagnostics, Product and Application
3.7 Global Key Players of Viral Molecular Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Molecular Diagnostics Breakdown Data by Type
4.1 Global Viral Molecular Diagnostics Historic Market Size by Type (2020-2025)
4.2 Global Viral Molecular Diagnostics Forecasted Market Size by Type (2026-2031)
5 Viral Molecular Diagnostics Breakdown Data by Application
5.1 Global Viral Molecular Diagnostics Historic Market Size by Application (2020-2025)
5.2 Global Viral Molecular Diagnostics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Viral Molecular Diagnostics Market Size (2020-2031)
6.2 North America Viral Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Viral Molecular Diagnostics Market Size by Country (2020-2025)
6.4 North America Viral Molecular Diagnostics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Viral Molecular Diagnostics Market Size (2020-2031)
7.2 Europe Viral Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Viral Molecular Diagnostics Market Size by Country (2020-2025)
7.4 Europe Viral Molecular Diagnostics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Viral Molecular Diagnostics Market Size (2020-2031)
8.2 Asia-Pacific Viral Molecular Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Viral Molecular Diagnostics Market Size by Region (2020-2025)
8.4 Asia-Pacific Viral Molecular Diagnostics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Viral Molecular Diagnostics Market Size (2020-2031)
9.2 Latin America Viral Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Viral Molecular Diagnostics Market Size by Country (2020-2025)
9.4 Latin America Viral Molecular Diagnostics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Viral Molecular Diagnostics Market Size (2020-2031)
10.2 Middle East & Africa Viral Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Viral Molecular Diagnostics Market Size by Country (2020-2025)
10.4 Middle East & Africa Viral Molecular Diagnostics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboraories
11.1.1 Abbott Laboraories Company Details
11.1.2 Abbott Laboraories Business Overview
11.1.3 Abbott Laboraories Viral Molecular Diagnostics Introduction
11.1.4 Abbott Laboraories Revenue in Viral Molecular Diagnostics Business (2020-2025)
11.1.5 Abbott Laboraories Recent Development
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Details
11.2.2 Bio-Rad Laboratories Business Overview
11.2.3 Bio-Rad Laboratories Viral Molecular Diagnostics Introduction
11.2.4 Bio-Rad Laboratories Revenue in Viral Molecular Diagnostics Business (2020-2025)
11.2.5 Bio-Rad Laboratories Recent Development
11.3 Becton, Dickinson
11.3.1 Becton, Dickinson Company Details
11.3.2 Becton, Dickinson Business Overview
11.3.3 Becton, Dickinson Viral Molecular Diagnostics Introduction
11.3.4 Becton, Dickinson Revenue in Viral Molecular Diagnostics Business (2020-2025)
11.3.5 Becton, Dickinson Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Viral Molecular Diagnostics Introduction
11.4.4 Roche Revenue in Viral Molecular Diagnostics Business (2020-2025)
11.4.5 Roche Recent Development
11.5 Gen-Probe
11.5.1 Gen-Probe Company Details
11.5.2 Gen-Probe Business Overview
11.5.3 Gen-Probe Viral Molecular Diagnostics Introduction
11.5.4 Gen-Probe Revenue in Viral Molecular Diagnostics Business (2020-2025)
11.5.5 Gen-Probe Recent Development
11.6 Qiagen
11.6.1 Qiagen Company Details
11.6.2 Qiagen Business Overview
11.6.3 Qiagen Viral Molecular Diagnostics Introduction
11.6.4 Qiagen Revenue in Viral Molecular Diagnostics Business (2020-2025)
11.6.5 Qiagen Recent Development
11.7 Olympus
11.7.1 Olympus Company Details
11.7.2 Olympus Business Overview
11.7.3 Olympus Viral Molecular Diagnostics Introduction
11.7.4 Olympus Revenue in Viral Molecular Diagnostics Business (2020-2025)
11.7.5 Olympus Recent Development
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Details
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific Viral Molecular Diagnostics Introduction
11.8.4 Thermo Fisher Scientific Revenue in Viral Molecular Diagnostics Business (2020-2025)
11.8.5 Thermo Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Viral Molecular Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Hepatitis B Virus (HBV)
 Table 3. Key Players of Hepatitis C Virus (HCV)
 Table 4. Key Players of Human Immunodeficiency Virus (HIV)
 Table 5. Key Players of Human Papillomavirus (HPV)
 Table 6. Global Viral Molecular Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Viral Molecular Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Viral Molecular Diagnostics Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Viral Molecular Diagnostics Market Share by Region (2020-2025)
 Table 10. Global Viral Molecular Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Viral Molecular Diagnostics Market Share by Region (2026-2031)
 Table 12. Viral Molecular Diagnostics Market Trends
 Table 13. Viral Molecular Diagnostics Market Drivers
 Table 14. Viral Molecular Diagnostics Market Challenges
 Table 15. Viral Molecular Diagnostics Market Restraints
 Table 16. Global Viral Molecular Diagnostics Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Viral Molecular Diagnostics Market Share by Players (2020-2025)
 Table 18. Global Top Viral Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Molecular Diagnostics as of 2024)
 Table 19. Ranking of Global Top Viral Molecular Diagnostics Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Viral Molecular Diagnostics Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Viral Molecular Diagnostics, Headquarters and Area Served
 Table 22. Global Key Players of Viral Molecular Diagnostics, Product and Application
 Table 23. Global Key Players of Viral Molecular Diagnostics, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Viral Molecular Diagnostics Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Viral Molecular Diagnostics Revenue Market Share by Type (2020-2025)
 Table 27. Global Viral Molecular Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Viral Molecular Diagnostics Revenue Market Share by Type (2026-2031)
 Table 29. Global Viral Molecular Diagnostics Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Viral Molecular Diagnostics Revenue Market Share by Application (2020-2025)
 Table 31. Global Viral Molecular Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Viral Molecular Diagnostics Revenue Market Share by Application (2026-2031)
 Table 33. North America Viral Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Viral Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Viral Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Viral Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Viral Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Viral Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Viral Molecular Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Viral Molecular Diagnostics Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Viral Molecular Diagnostics Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Viral Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Viral Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Viral Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Viral Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Viral Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Viral Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Abbott Laboraories Company Details
 Table 49. Abbott Laboraories Business Overview
 Table 50. Abbott Laboraories Viral Molecular Diagnostics Product
 Table 51. Abbott Laboraories Revenue in Viral Molecular Diagnostics Business (2020-2025) & (US$ Million)
 Table 52. Abbott Laboraories Recent Development
 Table 53. Bio-Rad Laboratories Company Details
 Table 54. Bio-Rad Laboratories Business Overview
 Table 55. Bio-Rad Laboratories Viral Molecular Diagnostics Product
 Table 56. Bio-Rad Laboratories Revenue in Viral Molecular Diagnostics Business (2020-2025) & (US$ Million)
 Table 57. Bio-Rad Laboratories Recent Development
 Table 58. Becton, Dickinson Company Details
 Table 59. Becton, Dickinson Business Overview
 Table 60. Becton, Dickinson Viral Molecular Diagnostics Product
 Table 61. Becton, Dickinson Revenue in Viral Molecular Diagnostics Business (2020-2025) & (US$ Million)
 Table 62. Becton, Dickinson Recent Development
 Table 63. Roche Company Details
 Table 64. Roche Business Overview
 Table 65. Roche Viral Molecular Diagnostics Product
 Table 66. Roche Revenue in Viral Molecular Diagnostics Business (2020-2025) & (US$ Million)
 Table 67. Roche Recent Development
 Table 68. Gen-Probe Company Details
 Table 69. Gen-Probe Business Overview
 Table 70. Gen-Probe Viral Molecular Diagnostics Product
 Table 71. Gen-Probe Revenue in Viral Molecular Diagnostics Business (2020-2025) & (US$ Million)
 Table 72. Gen-Probe Recent Development
 Table 73. Qiagen Company Details
 Table 74. Qiagen Business Overview
 Table 75. Qiagen Viral Molecular Diagnostics Product
 Table 76. Qiagen Revenue in Viral Molecular Diagnostics Business (2020-2025) & (US$ Million)
 Table 77. Qiagen Recent Development
 Table 78. Olympus Company Details
 Table 79. Olympus Business Overview
 Table 80. Olympus Viral Molecular Diagnostics Product
 Table 81. Olympus Revenue in Viral Molecular Diagnostics Business (2020-2025) & (US$ Million)
 Table 82. Olympus Recent Development
 Table 83. Thermo Fisher Scientific Company Details
 Table 84. Thermo Fisher Scientific Business Overview
 Table 85. Thermo Fisher Scientific Viral Molecular Diagnostics Product
 Table 86. Thermo Fisher Scientific Revenue in Viral Molecular Diagnostics Business (2020-2025) & (US$ Million)
 Table 87. Thermo Fisher Scientific Recent Development
 Table 88. Research Programs/Design for This Report
 Table 89. Key Data Information from Secondary Sources
 Table 90. Key Data Information from Primary Sources
 Table 91. Authors List of This Report


List of Figures
 Figure 1. Viral Molecular Diagnostics Picture
 Figure 2. Global Viral Molecular Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Viral Molecular Diagnostics Market Share by Type: 2024 VS 2031
 Figure 4. Hepatitis B Virus (HBV) Features
 Figure 5. Hepatitis C Virus (HCV) Features
 Figure 6. Human Immunodeficiency Virus (HIV) Features
 Figure 7. Human Papillomavirus (HPV) Features
 Figure 8. Global Viral Molecular Diagnostics Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Viral Molecular Diagnostics Market Share by Application: 2024 VS 2031
 Figure 10. Hospitals Case Studies
 Figure 11. Academics Institutions Case Studies
 Figure 12. Laboratories Case Studies
 Figure 13. Others Case Studies
 Figure 14. Viral Molecular Diagnostics Report Years Considered
 Figure 15. Global Viral Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Viral Molecular Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Viral Molecular Diagnostics Market Share by Region: 2024 VS 2031
 Figure 18. Global Viral Molecular Diagnostics Market Share by Players in 2024
 Figure 19. Global Top Viral Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Molecular Diagnostics as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Viral Molecular Diagnostics Revenue in 2024
 Figure 21. North America Viral Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Viral Molecular Diagnostics Market Share by Country (2020-2031)
 Figure 23. United States Viral Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Viral Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Viral Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Viral Molecular Diagnostics Market Share by Country (2020-2031)
 Figure 27. Germany Viral Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Viral Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Viral Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Viral Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Viral Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Viral Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Viral Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Viral Molecular Diagnostics Market Share by Region (2020-2031)
 Figure 35. China Viral Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Viral Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Viral Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Viral Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Viral Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Viral Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Viral Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Viral Molecular Diagnostics Market Share by Country (2020-2031)
 Figure 43. Mexico Viral Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Viral Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Viral Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Viral Molecular Diagnostics Market Share by Country (2020-2031)
 Figure 47. Turkey Viral Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Viral Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Viral Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Abbott Laboraories Revenue Growth Rate in Viral Molecular Diagnostics Business (2020-2025)
 Figure 51. Bio-Rad Laboratories Revenue Growth Rate in Viral Molecular Diagnostics Business (2020-2025)
 Figure 52. Becton, Dickinson Revenue Growth Rate in Viral Molecular Diagnostics Business (2020-2025)
 Figure 53. Roche Revenue Growth Rate in Viral Molecular Diagnostics Business (2020-2025)
 Figure 54. Gen-Probe Revenue Growth Rate in Viral Molecular Diagnostics Business (2020-2025)
 Figure 55. Qiagen Revenue Growth Rate in Viral Molecular Diagnostics Business (2020-2025)
 Figure 56. Olympus Revenue Growth Rate in Viral Molecular Diagnostics Business (2020-2025)
 Figure 57. Thermo Fisher Scientific Revenue Growth Rate in Viral Molecular Diagnostics Business (2020-2025)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS